Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $457.30 | Total: $2,286.50 |
| 1 | 10 | $387.36 | Total: $3,873.60 |
| 1 | 25 | $328.18 | Total: $8,204.50 |
| 1 | 50 | $279.76 | Total: $13,988.00 |
| 1 | 100 | $242.10 | Total: $24,210.01 |
Overview
IRAK4-IN-10 (compound 75) is a potent IRAK4 inhibitor (IC50 = 1.5 nM) that can block the MyD88-dependent signaling pathway and has research potential in inflammatory diseases, autoimmune diseases, and cancer.
Chemical Properties
| Molecular Formula | C22H24N8 |
| Molecular Weight | 400.48 |
| CAS Numbers | 2681278-09-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | N#CC=1C=CC=2C3=NC=C(C=4N=NN(C4)C5CCNCC5)C(NC(C)C)=C3NC2C1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Sabnis RW. Novel Tricyclic Heteroaryl Compounds as IRAK4 Inhibitors for Treating Cancer, Autoimmune and Inflammatory Diseases. ACS Med Chem Lett. 2022 Feb 28;13[3] 336-337.